NEW YORK (
) hit a new 52-week high Monday as it is currently trading at $3.88, above its previous 52-week high of $3.87 with 858,159 shares traded as of 3:58 p.m. ET. Average volume has been two million shares over the past 30 days.
Orthovita has a market cap of $296.6 million and is part of the
industry. Shares are up 90.5% year to date as of the close of trading on Friday.
Orthovita, Inc., a specialty spine and orthopedic company, develops and markets orthobiologic and biosurgery products.
- Practice your VITA trading strategies and win cash in our stock game.
TheStreet Ratings rates Orthovita as a
. The company's strengths can be seen in multiple areas, such as its solid stock price performance, good cash flow from operations and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we find that the company's return on equity has been disappointing. You can view the full
52-week high stocks
or get investment ideas from our